Loading…
Hyperbranched Polyglycerols as Trimodal Imaging Agents: Design, Biocompatibility, and Tumor Uptake
Combining various imaging modalities often leads to complementary information and synergistic advantages. A trimodal long-circulating imaging agent tagged with radioactive, magnetic resonance, and fluorescence markers is able to combine the high sensitivity of SPECT with the high resolution of MRI o...
Saved in:
Published in: | Bioconjugate chemistry 2012-03, Vol.23 (3), p.372-381 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-a341t-75ec4ab37ee03ab64e65fb1908de9497eb7cc0d26161825290a50f4d41a184873 |
---|---|
cites | cdi_FETCH-LOGICAL-a341t-75ec4ab37ee03ab64e65fb1908de9497eb7cc0d26161825290a50f4d41a184873 |
container_end_page | 381 |
container_issue | 3 |
container_start_page | 372 |
container_title | Bioconjugate chemistry |
container_volume | 23 |
creator | Saatchi, Katayoun Soema, Peter Gelder, Nikolaus Misri, Ripen McPhee, Kelly Baker, Jennifer H.E Reinsberg, Stefan A Brooks, Donald E Häfeli, Urs O |
description | Combining various imaging modalities often leads to complementary information and synergistic advantages. A trimodal long-circulating imaging agent tagged with radioactive, magnetic resonance, and fluorescence markers is able to combine the high sensitivity of SPECT with the high resolution of MRI over hours and days. The fluorescence marker helps to confirm the in vivo imaging information at the microscopic level, in the context of the tumor microenvironment. To make a trimodal long-circulating probe, high-molecular-weight hyperbranched polyglycerols (HPG) were modified with a suitable ligand for 111In radiolabeling and Gd coordination, and additionally tagged with a fluorescent dye. The resulting radiopharmaceutical and contrast agent was nontoxic and hemocompatible. Measured radioactively, its total tumor uptake increased from 2.6% at 24 h to 7.3% at 72 h, which is twice the increase expected due to tumor growth in this time period. Both in vivo MRI and subsequent histological analyses of the same tumors confirmed maximum HPG accumulation at 3 days post injection. Furthermore, Gd-derivatized HPG has an excellent contrast enhancement on T1-weighted MRI at 10× lower molar concentrations than commercially available Galbumin. HPG derivatized with gadolinium, radioactivity, and fluorescence are thus long-circulating macromolecules with great potential for imaging of healthy and leaky blood vessels using overlapping multimodal approaches and for the passive targeting of tumors. |
doi_str_mv | 10.1021/bc200280g |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_954768834</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2620967211</sourcerecordid><originalsourceid>FETCH-LOGICAL-a341t-75ec4ab37ee03ab64e65fb1908de9497eb7cc0d26161825290a50f4d41a184873</originalsourceid><addsrcrecordid>eNplkD1PwzAURS0EoqUw8AeQhcSA1MCz4yQOWykfrVQJhnaObMcJKUkc7GTIvyeopQxM7w1H5-pehC4J3BGg5F4qCkA55EdoTAIKHuOEHg8_MN8jHOgInTm3BYCYcHqKRpT6wCLCx0gu-kZbaUWtPnSK303Z52WvtDWlw8LhtS0qk4oSLyuRF3WOZ7muW_eAn7Qr8nqKHwujTNWItpBFWbT9FIs6xeuuMhZvmlZ86nN0konS6Yv9naDNy_N6vvBWb6_L-WzlCZ-R1osCrZiQfqQ1-EKGTIdBJkkMPNUxiyMtI6UgpSEJhxIBjUEEkLGUEUE445E_Qdc7b2PNV6ddm2xNZ-shMokDFoWc-2yAbneQssY5q7OkGRoK2ycEkp8xk8OYA3u1F3ay0umB_F1vAG52gFDuL-y_6BsArXpb</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>954768834</pqid></control><display><type>article</type><title>Hyperbranched Polyglycerols as Trimodal Imaging Agents: Design, Biocompatibility, and Tumor Uptake</title><source>American Chemical Society:Jisc Collections:American Chemical Society Read & Publish Agreement 2022-2024 (Reading list)</source><creator>Saatchi, Katayoun ; Soema, Peter ; Gelder, Nikolaus ; Misri, Ripen ; McPhee, Kelly ; Baker, Jennifer H.E ; Reinsberg, Stefan A ; Brooks, Donald E ; Häfeli, Urs O</creator><creatorcontrib>Saatchi, Katayoun ; Soema, Peter ; Gelder, Nikolaus ; Misri, Ripen ; McPhee, Kelly ; Baker, Jennifer H.E ; Reinsberg, Stefan A ; Brooks, Donald E ; Häfeli, Urs O</creatorcontrib><description>Combining various imaging modalities often leads to complementary information and synergistic advantages. A trimodal long-circulating imaging agent tagged with radioactive, magnetic resonance, and fluorescence markers is able to combine the high sensitivity of SPECT with the high resolution of MRI over hours and days. The fluorescence marker helps to confirm the in vivo imaging information at the microscopic level, in the context of the tumor microenvironment. To make a trimodal long-circulating probe, high-molecular-weight hyperbranched polyglycerols (HPG) were modified with a suitable ligand for 111In radiolabeling and Gd coordination, and additionally tagged with a fluorescent dye. The resulting radiopharmaceutical and contrast agent was nontoxic and hemocompatible. Measured radioactively, its total tumor uptake increased from 2.6% at 24 h to 7.3% at 72 h, which is twice the increase expected due to tumor growth in this time period. Both in vivo MRI and subsequent histological analyses of the same tumors confirmed maximum HPG accumulation at 3 days post injection. Furthermore, Gd-derivatized HPG has an excellent contrast enhancement on T1-weighted MRI at 10× lower molar concentrations than commercially available Galbumin. HPG derivatized with gadolinium, radioactivity, and fluorescence are thus long-circulating macromolecules with great potential for imaging of healthy and leaky blood vessels using overlapping multimodal approaches and for the passive targeting of tumors.</description><identifier>ISSN: 1043-1802</identifier><identifier>EISSN: 1520-4812</identifier><identifier>DOI: 10.1021/bc200280g</identifier><identifier>PMID: 22304718</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Biocompatible Materials ; Cells, Cultured ; Chemical compounds ; Complement Activation ; Erythrocytes - cytology ; Fluorescence ; Glycerol - metabolism ; Glycerol - pharmacokinetics ; Humans ; Molecular weight ; Neoplasms - metabolism ; NMR ; Nuclear magnetic resonance ; Polymers - metabolism ; Polymers - pharmacokinetics ; Thrombelastography ; Tissue Distribution ; Tomography, Emission-Computed, Single-Photon ; Tumors</subject><ispartof>Bioconjugate chemistry, 2012-03, Vol.23 (3), p.372-381</ispartof><rights>Copyright © 2012 American Chemical Society</rights><rights>Copyright American Chemical Society Mar 21, 2012</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a341t-75ec4ab37ee03ab64e65fb1908de9497eb7cc0d26161825290a50f4d41a184873</citedby><cites>FETCH-LOGICAL-a341t-75ec4ab37ee03ab64e65fb1908de9497eb7cc0d26161825290a50f4d41a184873</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22304718$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Saatchi, Katayoun</creatorcontrib><creatorcontrib>Soema, Peter</creatorcontrib><creatorcontrib>Gelder, Nikolaus</creatorcontrib><creatorcontrib>Misri, Ripen</creatorcontrib><creatorcontrib>McPhee, Kelly</creatorcontrib><creatorcontrib>Baker, Jennifer H.E</creatorcontrib><creatorcontrib>Reinsberg, Stefan A</creatorcontrib><creatorcontrib>Brooks, Donald E</creatorcontrib><creatorcontrib>Häfeli, Urs O</creatorcontrib><title>Hyperbranched Polyglycerols as Trimodal Imaging Agents: Design, Biocompatibility, and Tumor Uptake</title><title>Bioconjugate chemistry</title><addtitle>Bioconjugate Chem</addtitle><description>Combining various imaging modalities often leads to complementary information and synergistic advantages. A trimodal long-circulating imaging agent tagged with radioactive, magnetic resonance, and fluorescence markers is able to combine the high sensitivity of SPECT with the high resolution of MRI over hours and days. The fluorescence marker helps to confirm the in vivo imaging information at the microscopic level, in the context of the tumor microenvironment. To make a trimodal long-circulating probe, high-molecular-weight hyperbranched polyglycerols (HPG) were modified with a suitable ligand for 111In radiolabeling and Gd coordination, and additionally tagged with a fluorescent dye. The resulting radiopharmaceutical and contrast agent was nontoxic and hemocompatible. Measured radioactively, its total tumor uptake increased from 2.6% at 24 h to 7.3% at 72 h, which is twice the increase expected due to tumor growth in this time period. Both in vivo MRI and subsequent histological analyses of the same tumors confirmed maximum HPG accumulation at 3 days post injection. Furthermore, Gd-derivatized HPG has an excellent contrast enhancement on T1-weighted MRI at 10× lower molar concentrations than commercially available Galbumin. HPG derivatized with gadolinium, radioactivity, and fluorescence are thus long-circulating macromolecules with great potential for imaging of healthy and leaky blood vessels using overlapping multimodal approaches and for the passive targeting of tumors.</description><subject>Biocompatible Materials</subject><subject>Cells, Cultured</subject><subject>Chemical compounds</subject><subject>Complement Activation</subject><subject>Erythrocytes - cytology</subject><subject>Fluorescence</subject><subject>Glycerol - metabolism</subject><subject>Glycerol - pharmacokinetics</subject><subject>Humans</subject><subject>Molecular weight</subject><subject>Neoplasms - metabolism</subject><subject>NMR</subject><subject>Nuclear magnetic resonance</subject><subject>Polymers - metabolism</subject><subject>Polymers - pharmacokinetics</subject><subject>Thrombelastography</subject><subject>Tissue Distribution</subject><subject>Tomography, Emission-Computed, Single-Photon</subject><subject>Tumors</subject><issn>1043-1802</issn><issn>1520-4812</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNplkD1PwzAURS0EoqUw8AeQhcSA1MCz4yQOWykfrVQJhnaObMcJKUkc7GTIvyeopQxM7w1H5-pehC4J3BGg5F4qCkA55EdoTAIKHuOEHg8_MN8jHOgInTm3BYCYcHqKRpT6wCLCx0gu-kZbaUWtPnSK303Z52WvtDWlw8LhtS0qk4oSLyuRF3WOZ7muW_eAn7Qr8nqKHwujTNWItpBFWbT9FIs6xeuuMhZvmlZ86nN0konS6Yv9naDNy_N6vvBWb6_L-WzlCZ-R1osCrZiQfqQ1-EKGTIdBJkkMPNUxiyMtI6UgpSEJhxIBjUEEkLGUEUE445E_Qdc7b2PNV6ddm2xNZ-shMokDFoWc-2yAbneQssY5q7OkGRoK2ycEkp8xk8OYA3u1F3ay0umB_F1vAG52gFDuL-y_6BsArXpb</recordid><startdate>20120321</startdate><enddate>20120321</enddate><creator>Saatchi, Katayoun</creator><creator>Soema, Peter</creator><creator>Gelder, Nikolaus</creator><creator>Misri, Ripen</creator><creator>McPhee, Kelly</creator><creator>Baker, Jennifer H.E</creator><creator>Reinsberg, Stefan A</creator><creator>Brooks, Donald E</creator><creator>Häfeli, Urs O</creator><general>American Chemical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7TM</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20120321</creationdate><title>Hyperbranched Polyglycerols as Trimodal Imaging Agents: Design, Biocompatibility, and Tumor Uptake</title><author>Saatchi, Katayoun ; Soema, Peter ; Gelder, Nikolaus ; Misri, Ripen ; McPhee, Kelly ; Baker, Jennifer H.E ; Reinsberg, Stefan A ; Brooks, Donald E ; Häfeli, Urs O</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a341t-75ec4ab37ee03ab64e65fb1908de9497eb7cc0d26161825290a50f4d41a184873</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Biocompatible Materials</topic><topic>Cells, Cultured</topic><topic>Chemical compounds</topic><topic>Complement Activation</topic><topic>Erythrocytes - cytology</topic><topic>Fluorescence</topic><topic>Glycerol - metabolism</topic><topic>Glycerol - pharmacokinetics</topic><topic>Humans</topic><topic>Molecular weight</topic><topic>Neoplasms - metabolism</topic><topic>NMR</topic><topic>Nuclear magnetic resonance</topic><topic>Polymers - metabolism</topic><topic>Polymers - pharmacokinetics</topic><topic>Thrombelastography</topic><topic>Tissue Distribution</topic><topic>Tomography, Emission-Computed, Single-Photon</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Saatchi, Katayoun</creatorcontrib><creatorcontrib>Soema, Peter</creatorcontrib><creatorcontrib>Gelder, Nikolaus</creatorcontrib><creatorcontrib>Misri, Ripen</creatorcontrib><creatorcontrib>McPhee, Kelly</creatorcontrib><creatorcontrib>Baker, Jennifer H.E</creatorcontrib><creatorcontrib>Reinsberg, Stefan A</creatorcontrib><creatorcontrib>Brooks, Donald E</creatorcontrib><creatorcontrib>Häfeli, Urs O</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Bioconjugate chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Saatchi, Katayoun</au><au>Soema, Peter</au><au>Gelder, Nikolaus</au><au>Misri, Ripen</au><au>McPhee, Kelly</au><au>Baker, Jennifer H.E</au><au>Reinsberg, Stefan A</au><au>Brooks, Donald E</au><au>Häfeli, Urs O</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hyperbranched Polyglycerols as Trimodal Imaging Agents: Design, Biocompatibility, and Tumor Uptake</atitle><jtitle>Bioconjugate chemistry</jtitle><addtitle>Bioconjugate Chem</addtitle><date>2012-03-21</date><risdate>2012</risdate><volume>23</volume><issue>3</issue><spage>372</spage><epage>381</epage><pages>372-381</pages><issn>1043-1802</issn><eissn>1520-4812</eissn><abstract>Combining various imaging modalities often leads to complementary information and synergistic advantages. A trimodal long-circulating imaging agent tagged with radioactive, magnetic resonance, and fluorescence markers is able to combine the high sensitivity of SPECT with the high resolution of MRI over hours and days. The fluorescence marker helps to confirm the in vivo imaging information at the microscopic level, in the context of the tumor microenvironment. To make a trimodal long-circulating probe, high-molecular-weight hyperbranched polyglycerols (HPG) were modified with a suitable ligand for 111In radiolabeling and Gd coordination, and additionally tagged with a fluorescent dye. The resulting radiopharmaceutical and contrast agent was nontoxic and hemocompatible. Measured radioactively, its total tumor uptake increased from 2.6% at 24 h to 7.3% at 72 h, which is twice the increase expected due to tumor growth in this time period. Both in vivo MRI and subsequent histological analyses of the same tumors confirmed maximum HPG accumulation at 3 days post injection. Furthermore, Gd-derivatized HPG has an excellent contrast enhancement on T1-weighted MRI at 10× lower molar concentrations than commercially available Galbumin. HPG derivatized with gadolinium, radioactivity, and fluorescence are thus long-circulating macromolecules with great potential for imaging of healthy and leaky blood vessels using overlapping multimodal approaches and for the passive targeting of tumors.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>22304718</pmid><doi>10.1021/bc200280g</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1043-1802 |
ispartof | Bioconjugate chemistry, 2012-03, Vol.23 (3), p.372-381 |
issn | 1043-1802 1520-4812 |
language | eng |
recordid | cdi_proquest_journals_954768834 |
source | American Chemical Society:Jisc Collections:American Chemical Society Read & Publish Agreement 2022-2024 (Reading list) |
subjects | Biocompatible Materials Cells, Cultured Chemical compounds Complement Activation Erythrocytes - cytology Fluorescence Glycerol - metabolism Glycerol - pharmacokinetics Humans Molecular weight Neoplasms - metabolism NMR Nuclear magnetic resonance Polymers - metabolism Polymers - pharmacokinetics Thrombelastography Tissue Distribution Tomography, Emission-Computed, Single-Photon Tumors |
title | Hyperbranched Polyglycerols as Trimodal Imaging Agents: Design, Biocompatibility, and Tumor Uptake |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T23%3A04%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hyperbranched%20Polyglycerols%20as%20Trimodal%20Imaging%20Agents:%20Design,%20Biocompatibility,%20and%20Tumor%20Uptake&rft.jtitle=Bioconjugate%20chemistry&rft.au=Saatchi,%20Katayoun&rft.date=2012-03-21&rft.volume=23&rft.issue=3&rft.spage=372&rft.epage=381&rft.pages=372-381&rft.issn=1043-1802&rft.eissn=1520-4812&rft_id=info:doi/10.1021/bc200280g&rft_dat=%3Cproquest_cross%3E2620967211%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-a341t-75ec4ab37ee03ab64e65fb1908de9497eb7cc0d26161825290a50f4d41a184873%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=954768834&rft_id=info:pmid/22304718&rfr_iscdi=true |